Stand aside — setup invalidated
Setup score 51, but distribution days reach 5 or more — stand aside until the condition resets.
Simple research view
TMO · Thermo Fisher Scientific Inc
$603.18 -0.41% Sep 10 close
Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.
$TMO
Thermo Fisher Scientific IncThermo Fisher Scientific Inc is a mega-cap Medical Specialties company in the Health Technology sector with a market cap of $223B.
Verdict · setup score 51/100 · data Sep 10 close · 1 session old
Stand aside — setup invalidated
Setup score 51, but distribution days reach 5 or more — stand aside until the condition resets.
Earnings
Normal technical setup
Next earnings
Tuesday, October 20, 2026
Before market open
Exact clock time not supplied by source
Deterministic evidence
TMO-0.41%
Sector proxy · XLV-0.55%
Broad market · SPY-0.60%
Session internals Mixed
Rule: direction and internals disagree — it met neither the strong nor the weak rule. Judged on internals, not on the size of the move.
Vs prior close-0.41%
From the open-0.12%
Range position71%
GapNo gap
QQQ confirmationConfirming (-1.06%)
SMH confirmationConfirming (-2.44%)
Ask a Legend to interpret this evidence → Commentary only — never scanner evidence or a sizing recommendation.
More stats
52W Low
$435.27
Tight Wks
0
Base
B1
SMA 200
$536.52
RS Line vs High
-14.3%
RS Line Slope
+3.9% ▲
Group Rank
#25/58
ADR%
2.4%
ATR(14)
$15.41 (2.6%)
Vol Pace (live)
N/A
U/D Vol
1.11
A/D Days
18A / 12D
A/D Rating
A+
VDU Bars
0/10 d
Earnings
in 38d
TMO Chart
Interactive price, volume, RS, RSI, and MACD charts are available after sign in.
Technical Analysis Report Card
$TMO · $603.18 · as of 2026-09-10 · multi-factor read
75
/ 100
Reference read from price & volume only — the verdict at the top of the page decides the action.
Trend · Daily / Weekly / Monthly
Daily
▬ Sideways / consolidating
Weekly
▲ Uptrend
Monthly
▲ Uptrend
Moving Averages
50-day$576.56 ↑
100-day$525.11 ↑
200-day$536.52 ↑
Bullish (50 > 200)
RSI (14)
Reading51.5 · Neutral
Neutral — momentum is balanced between buyers and sellers.
MACD (12/26/9)
StateWeakening
Histogram-4.880
Weakening — MACD slipped below its signal line. Histogram contracting.
Bollinger Bands (20,2)
%B / Width35% · 10.0%
Squeeze — volatility compressing
Mid-band — no directional band edge in play. Bands are squeezing — volatility is compressing, often a precursor to a sharp move.
Volume · Buyer vs Seller
Up/Down vol1.11 · Neutral
Rel volume0.8×
Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.
Support & Resistance
R · $647.0052-week high
Price · $603.18now
S · $580.00swing level
S · $494.34swing level
S · $457.48swing level
Fibonacci · Uptrend swing
23.6% ◄ price here$597.03
38.2%$566.12
50.0%$541.13
61.8%$516.15
78.6%$480.58
Retracement support zones measured from the recent swing low up to the high.
The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for TMO — plus the full 500+ symbol scanner and Ask-the-Legends chat.
Start your 7-day free trial →
Weekly uptrendMonthly uptrendAbove 200-day MA50/200 bullish
Want this read in a legend's voice?
Ask a Legend about TMO
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts
6 methodology checks
Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.
Council consensus:
4 of 6 legends are Watching — building, not yet a confirmed buy.
Avoid
Minervini D
Trend-template read: fails 150-day MA > 200-day MA.
Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $603.18, MA150 $517.83, MA200 $536.52
1.4 50-day MA > 150-day MA AND 200-day MAMA50 $576.56, MA150 $517.83, MA200 $536.52
Failing evidence
1.2 150-day MA > 200-day MAMA150 $517.83 vs MA200 $536.52
1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 62
Avoid
O'Neil D
CANSLIM read: fails L: RS rank ≥ 80 (IBD leadership).
Passing evidence
C: Quarterly EPS acceleration ≥ 25%CANSLIM grade B
N: Near 52-week high or RS line new high6.8% below high | RS line new high: False
Failing evidence
L: RS rank ≥ 80 (IBD leadership)RS rank 62
A: Annual earnings & revenue qualityRev +3.9%
Watch
Weinstein B
Stage-analysis read: Stage 2 is present; 1 supporting checks need improvement.
Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $603.18 vs MA200 $536.52
Failing evidence
Volume expansion above averageVolume ratio 0.80x
Watch
Livermore B
Pivotal-point read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$603.18
Distance from 52-week high6.8% below high
Failing evidence
Relative strengthRS 62
Volume vs average0.80x
Watch
Darvas B
Box-theory read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$603.18
Distance from 52-week high6.8% below high
Failing evidence
Relative strengthRS 62
Volume vs average0.80x
Watch
Wyckoff B
Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.
Passing evidence
Price$603.18
Distance from 52-week high6.8% below high
Failing evidence
Relative strengthRS 62
Volume vs average0.80x
Base & Breakout
Breakout follow-through
No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?
Latest candle: Doji — Open and close nearly equal — indecision. After a strong move it can signal a pause or pending reversal; wait for confirmation.
RS Line vs SPY
52-week relative strength · blue = RS line · dashed = MA50 · dot = NH
▲ Rising
Accumulation / Distribution
last 65 sessions · green = acc on high vol · red = dist on high vol
Net +9
Fundamentals & leadership quality — Minervini’s published criteria · 2/7 met
C
2/7 criteria
Separate score from the Minervini Trend Template (6/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ
—
Revenue growth ≥20% YoY
+4%
Gross margin ≥30%
—
ROE ≥17%
—
RS rating ≥80 (leadership)
62
Stage 2 uptrend (Weinstein)
Stage 2
Within 25% of 52W high
-6.8%
Method Playbook
Trade it like O'Neil
EXACT LEVELS · PRO
O'Neil D · Avoid — The deterministic methodology check is Avoid; wait until the blocking criteria are resolved.
Pivot
Pro levelPublished-method rule: Use the proper base pivot or handle high after CANSLIM leadership and market-direction checks are satisfied.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro levelPublished-method rule: Require a breakout through the pivot on volume at least 40% above average; the valid buy zone ends 5% above the pivot.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro levelPublished-method rule: Use the setup's structural stop with a hard 7–8% maximum-loss ceiling from the actual entry.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-basedPublished-method rule: Protect progress under constructive support such as the 21-day or 10-week line; a stop may ratchet higher but never lower.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro levelPublished-method rule: Exit on the hard loss limit, a decisive support break, or a rule-based climax/distribution signal; a normal 20–25% advance is reviewed rather than assumed permanent.
Evidence: Canonical setup geometry is available with Pro.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →
The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →
Pattern Analysis
Wyckoff SOS
Historical replay: +20% before −8% within 40 sessions: 27% (n=71) · source bars 2025-03-17–2026-09-04 · avg +4.1% per setup (+0.52R)
⚠ Volatility widening into breakout
⚠ Extended past buy zone
⚠ Not actionable yet
51
setup score
RS Score
62
Trend template
6/8
CANSLIM
66.0* (B)
range low: 454.363
range high: 522.826
range pct: 0.151
sos thrust: 0.2
sos vol ratio: 1.249
sos bars ago: 14
near lps: ✗
validation reason: valid generic setup
multi tf evaluated: ✓
multi tf reason: weekly: MA stabilizing or rising — accumulation context supported
Why This Setup?
D+W Confluence
Wyckoff SOS · schematic
SOS: breakout above range_high=522.83, thrust=20.0%, vol=1.2x avg, lps=extended, 14 bars ago | Moderate trend (6/8) | Good RS (62) | Moderate pattern (63%) | Stage 2 | Readiness 51/100 (early) | CANSLIM 66.0 (B) | ⚠ Volatility widening into breakout; Extended past buy zone; Not actionable yet
The Universal Edge Check · context only
What the setup still has going for it, recorded for later. The verdict above stands — these principles do not overrule it.
2/7
universals met
- A relative-strength leader — not met RS rank 54 — laggard
- Risk is defined — not met No stop — undefined risk
- Asymmetric reward — partly met No target set
- Not chasing (in range) — partly met Pivot distance unknown
- Volume confirms — partly met 0.8× average — light
- Clear of earnings — met in 38 days
- In a confirmed uptrend — met Stage 2 · Trend template 6/8
Minervini Trend Template
6/8Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.
Price above SMA 150 & 200
$603.18 vs SMA150 $517.83 / SMA200 $536.52
SMA 150 above SMA 200
SMA150 $517.83 vs SMA200 $536.52
SMA 200 trending up
Slope +4.16 over 20 days
SMA 50 above SMA 150 & 200
SMA50 $576.56
Price above SMA 50
$603.18 vs SMA50 $576.56
30%+ above 52-week low
+38.6% from $435.27
Within 25% of 52-week high
-6.8% from $647.00
RS score above 70
RS 62
Fundamentals
52W Range
79%
Mkt Cap SEC
223.0B
Rev YoY
+4%
EPS TTM
$17.74
P/E TTM
34.0x
Float
370M
Company
Company profile
Thermo Fisher Scientific Inc
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
B
66.0* CANSLIM
* disqualified on M
C · Curr. EPS
70
A · Annual EPS
60
N · New Highs
100
S · Supply/Demand
70
L · Leader RS
62
I · Inst. Spons.
100
M · Market
30
Weekly Context
Multi-timeframe signals from weekly barsW. Trend
7/8
W. RS
82
W. Support
$435.27
W. Resist
$647.00
W. Patterns
Cup & Handle
Weekly Structure
Trend
Neutral
Tight Weeks
0
Confirmation
Neutral
Scan History
20× streakSep 11
Wyckoff SOS
✓ Gate
51
Sep 11
Wyckoff SOS
✓ Gate
49
Sep 10
Wyckoff SOS
✓ Gate
47
0.0%
Sep 10
Wyckoff SOS
✓ Gate
47
0.0%
Sep 10
Wyckoff SOS
✓ Gate
47
0.0%
Sep 09
Wyckoff SOS
✓ Gate
47
-0.4%
Get the full picture on TMO
Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 500+ symbols daily.
Start 7-Day Free Trial